Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps
Role of Continuous Local Infusion of Ropivacaine for Post-Operative Pain Management in Patients Receiving Osseocutaneous Free Flaps
Sponsor: Icahn School of Medicine at Mount Sinai
Listed as NCT03349034, this PHASE2 trial focuses on Free Tissue Transfer and Head and Neck Cancer and remains completed. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Jul 2020 — Dec 2020 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jul 2019 — Jul 2020 [monthly]
Recruiting PHASE2
-
Nov 2018 — Jul 2019 [monthly]
Recruiting PHASE2
-
Dec 2017 — Nov 2018 [monthly]
Recruiting PHASE2
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .